Current Standard and Investigational Approaches to the Management of Hormone-Refractory Prostate Cancer

Prostate cancer is a common cause of death in men and remains incurable in the metastatic setting. In 2004, 2 landmark trials using docetaxel-based chemotherapy, TAX 327 and SWOG 99-16, showed a survival benefit for the first time in metastatic, hormone-refractory prostate cancer. Current research s...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Mendiratta, Prateek, Armstrong, Andrew J, George, Daniel J
Format: Artigo
Jezik:Inglês
Izdano: MedReviews, LLC 2007
Teme:
New Directions in Prostate Cancer Management
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1831542/
https://ncbi.nlm.nih.gov/pubmed/17387372
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki